Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N23-2076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N23-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
filingDate |
2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08bc11155ef50e8d7b8b831351364125 |
publicationDate |
2016-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20160067197-A |
titleOfInvention |
Method for predicting weight gain associated with a pharmaceutical therapy |
abstract |
The present invention provides a method of using TRL V6 as a biomarker for the risk of weight gain associated with the treatment of a patient with, for example, a pharmaceutical agent such as olanzapine. |
priorityDate |
2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |